Avalon GloboCare (ALBT) - Return on Sales by Net Profit

Official company branding of Avalon GloboCare Corp (ALBT)

The integral net margin indicator demonstrates the pressure of fixed US government insurance rates on the profitability of Avalon GloboCare (ALBT). -1743.80 captures the current state of this parameter. Growth is based on the expansion of the distribution network and the implementation of new diagnostic systems. Efficiency is sustained by attracting top cell technology researchers, who are motivated by competitive salaries and stable funding for their scientific developments.

Avalon GloboCare Corp. (ALBT) - Net Profitability Margin from 04/28/2023 to 07/22/2026

Analytical breakdowns for Avalon GloboCare

- market value and analyst target forecast:
Fundamental valuation:Avalon GloboCare
Manufactured product of Avalon GloboCare

To protect capital amid uncertainty, it is essential for investors to evaluate the efficiency of converting revenue into net income. This indicator measures the share of profit after all expenses, reflecting the business's resilience to rising costs and debt burdens. By analyzing relative net profit from sales, one can identify a company's hidden vulnerability to external shocks. For Avalon GloboCare (ALBT), such dynamics are critical, as the aggressive expansion of laboratories is depleting reserves. The current operating deficit makes margin the primary indicator of business viability.

Analysis of competing companies

HCA: Net Sales Margin|Tenet Healthcare Corporation - Net Profit Rate|Return on Sales by Net Profit FMS|SOLV (Solventum Corporation) - Company Net Profitability|Net Margin encompasshealth.com (EHC)|Net Margin UHS (Universal Health Services Corp)|Net Sales Margin DVA (DaVita HealthCare Partners)|RDNT: Net Return on Sales|OPCH - Net Margin|SGRY - Net Sales Margin|PINC: Net Sales Margin|EYE - Company Sales Margin|Return on Sales by Net Profit PGNY|ARDT (Ardent Health Partners) - Company Net Profitability|Net Margin Select Medical Corp (SEM)|Company Net Profitability ASTH|Net Sales Margin MD (Pediatrix Medical Group, Inc.)|Net Profit Rate USPH|PNTG - Net Margin|Net Profit Rate ORGO (Organogenesis Holdings Inc.)|NUTX: Net Sales Margin|AUNA: Company Net Profitability|Return on Sales by Net Profit SBC|EOLS: Net Profit Rate|Return on Sales by Net Profit CYH (Community Health Corp)|Company Sales Margin The Beauty Health Company|MediWound - Return on Sales by Net Profit|Net Sales Margin biote Corp. BTMD|JYNT: Return on Sales by Net Profit|DocGo Inc. (DCGO) - Return on Sales by Net Profit|Net Return on Sales P3 Health Partners|Return on Sales by Net Profit Gain Therapeutics|EUDA (euda.com) - Net Sales Margin|BMGL - Net Profitability Margin|Net Sales Margin CLGN|Cuprina Holdings - Net Return on Sales|Net Sales Margin CCM (Concord Medical Services Holdings)|Net Sales Margin American Shared Hospital Services Inc AMS|MRM - Net Margin|Net Profit Rate DHAI (DIH Holding US Inc.)|XAGE (Carmell Therapeutics) - Return on Sales by Net Profit|NIVF (NewGenIvf Group Limited) - Net Margin|ATIP (ATI Physical Therapy Inc.) - Net Sales Margin|Net Sales Margin CareMax Inc.|Net Margin Kindly MD Inc (KDLY)|Return on Sales by Net Profit ModivCare Corp MODV|Novo Integrated - Return on Sales by Net Profit|Company Net Profitability SSY (SunLink Health Systems)|BACK - Net Margin